How Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine Returns

Emergent BioSolutions was awarded a $628 million federal contract with no competitive bidding. Top executives received big bonuses while factories mostly sat idle and tens of millions of Covid-19 doses were thrown away.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Emergent BioSolutions Inc Johnson & AstraZeneca PLC Government Contracts and Procurement Coronavirus (2019-nCoV) Vaccination and Immunization Health and Human Services Department Food and Drug Administration Kadlec, Robert P Trump, Don Source Type: news